Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Operating Margin Growth (1y) (2019 - 2026)

Analysis

Verastem (VSTM) Operating Margin Growth (1y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 78.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1,135.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7,666.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1,238.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2,002.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -1,651.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 29,091.00
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 196,630.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 196,630.00
Jun 30, 2025 -186,515.00
Mar 31, 2022 74,830.00
Dec 31, 2021 28,153.00
Sep 30, 2021 -74.23 Mn
Jun 30, 2021 -269,509.00
Mar 31, 2021 -88,104.00
Dec 31, 2020 -239,066.00
Sep 30, 2020 30,810.00
Jun 30, 2020 72,686.00
Mar 31, 2020 155,346.00
Dec 31, 2019 191,092.00
Sep 30, 2019 -14,992.00
Jun 30, 2019 -103,863.00